| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 589 | 2016 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice R Gordon, EA Albornoz, DC Christie, MR Langley, V Kumar, S Mantovani, ... Science translational medicine 10 (465), eaah4066, 2018 | 577 | 2018 |
| An inflammatory review of Parkinson’s disease CF Orr, DB Rowe, GM Halliday Progress in neurobiology 68 (5), 325-340, 2002 | 427 | 2002 |
| Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ... JAMA neurology 70 (10), 1277-1287, 2013 | 420 | 2013 |
| A possible role for humoral immunity in the pathogenesis of Parkinson's disease CF Orr, DB Rowe, Y Mizuno, H Mori, GM Halliday Brain 128 (11), 2665-2674, 2005 | 392 | 2005 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 381 | 2018 |
| Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease W Le, D Rowe, W Xie, I Ortiz, Y He, SH Appel Journal of Neuroscience 21 (21), 8447-8455, 2001 | 364 | 2001 |
| Right parietal cortex is involved in the perception of sound movement in humans TD Griffiths, G Rees, A Rees, GGR Green, C Witton, D Rowe, C Büchel, ... Nature neuroscience 1 (1), 74-79, 1998 | 354 | 1998 |
| Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021 | 278 | 2021 |
| Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test KL Double, DB Rowe, M Hayes, DKY Chan, J Blackie, A Corbett, R Joffe, ... Archives of neurology 60 (4), 545-549, 2003 | 205 | 2003 |
| Reduced T helper and B lymphocytes in Parkinson's disease CH Stevens, D Rowe, MC Morel-Kopp, C Orr, T Russell, M Ranola, ... Journal of neuroimmunology 252 (1-2), 95-99, 2012 | 192 | 2012 |
| Neurological abnormalities in familial and sporadic schizophrenia. TD Griffiths, T Sigmundsson, N Takei, D Rowe, RM Murray Brain: a journal of neurology 121 (2), 191-203, 1998 | 155 | 1998 |
| Neuroprotection by pramipexole against dopamine-and levodopa-induced cytotoxicity L Zou, J Jankovic, DB Rowe, W Xie, SH Appel, W Le Life sciences 64 (15), 1275-1285, 1999 | 151 | 1999 |
| Genetic correlation between amyotrophic lateral sclerosis and schizophrenia RL McLaughlin, D Schijven, W Van Rheenen, KR Van Eijk, M O’brien, ... Nature communications 8 (1), 14774, 2017 | 136 | 2017 |
| Genetic contributions to Parkinson's disease Y Huang, L Cheung, D Rowe, G Halliday Brain research reviews 46 (1), 44-70, 2004 | 129 | 2004 |
| Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls B Mollenhauer, CJ Caspell-Garcia, CS Coffey, P Taylor, LM Shaw, ... Neurology 89 (19), 1959-1969, 2017 | 115 | 2017 |
| Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross … T Simuni, L Uribe, HR Cho, C Caspell-Garcia, CS Coffey, A Siderowf, ... The Lancet Neurology 19 (1), 71-80, 2020 | 106 | 2020 |
| Assessment of disease progression in motor neuron disease JMC Winhammar, DB Rowe, RD Henderson, MC Kiernan The Lancet Neurology 4 (4), 229-238, 2005 | 102 | 2005 |
| Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis B Benyamin, J He, Q Zhao, J Gratten, F Garton, PJ Leo, Z Liu, ... Nature communications 8 (1), 611, 2017 | 93 | 2017 |
| Anti-melanin antibodies are increased in sera in Parkinson's disease KL Double, DB Rowe, FM Carew-Jones, M Hayes, DKY Chan, J Blackie, ... Experimental neurology 217 (2), 297-301, 2009 | 92 | 2009 |
Glenda HallidayBrain & Mind Centre, Sydney Medical School, the University of SydneyVerified email at sydney.edu.au
